Rhonda Lynette Hellums
Chief Financial Officer, ARATANA THERAPEUTICS, INC.
Companies
- Silence TherapeuticsBoard member Jan 6, 2026 to now1
- Silence TherapeuticsChief financial officer Jan 2, 2025 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Silence Therapeutics SLN1,500 shares3$29.4K at $19.57Jan 2, 2025
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARSilence Therapeutics, Board member
- 2
- 3